a developer of novel therapeutics for serious unmet medical needs
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with AMLX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then AMLX could also see price increases.
Ticker / NAME | Correlation To ATRA | 1D Price Change % | ||
---|---|---|---|---|
ATRA | 100% | -10.45% | ||
AMLX - ATRA | 65% Loosely correlated | -11.62% | ||
GRI - ATRA | 39% Loosely correlated | +9.12% | ||
SLRX - ATRA | 37% Loosely correlated | -2.13% | ||
NTLA - ATRA | 36% Loosely correlated | -6.15% | ||
FULC - ATRA | 35% Loosely correlated | -6.74% | ||
More |
Ticker / NAME | Correlation To ATRA | 1D Price Change % |
---|---|---|
ATRA | 100% | -10.45% |
ATRA (2 stocks) | 98% Closely correlated | -11.03% |
stem cells (21 stocks) | 25% Poorly correlated | -3.36% |
therapeutics (53 stocks) | 16% Poorly correlated | -2.40% |
drugs (254 stocks) | 13% Poorly correlated | -1.67% |
biotechnology (238 stocks) | 3% Poorly correlated | -1.76% |